FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Catherine Evans

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Rhys D Clyburn; Penny Reid; Catherine A Evans; Diane V Lefley; Ingunn Holen
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
Simon Cross; Robert F Harrison; Sabapathy P Balasubramanian; Jennifer M Lippitt; Catherine A Evans; M W R Reed; Ingunn Holen
Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
Simon Cross; Zhiyong Yang; Nicola J Brown; Sabapathy P Balasubramanian; Catherine A Evans; Julia K L Woodward; Helen L Neville-Webbe; Jennifer M Lippitt; M W R Reed; Robert E Coleman; Ingunn Holen
Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Catherine Evans (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Rhys D Clyburn; Penny Reid; Catherine A Evans; Diane V Lefley; Ingunn Holen
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
Cancer chemotherapy and pharmacology 2010;65(5):969-78.
2006: Simon Cross; Robert F Harrison; Sabapathy P Balasubramanian; Jennifer M Lippitt; Catherine A Evans; M W R Reed; Ingunn Holen
Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
Journal of clinical pathology 2006;59(7):716-20.
2006: Simon Cross; Zhiyong Yang; Nicola J Brown; Sabapathy P Balasubramanian; Catherine A Evans; Julia K L Woodward; Helen L Neville-Webbe; Jennifer M Lippitt; M W R Reed; Robert E Coleman; Ingunn Holen
Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
International journal of cancer. Journal international du cancer 2006;118(8):1901-8.
2006: Helen L Neville-Webbe; Catherine A Evans; Robert E Coleman; Ingunn Holen
Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(2):92-103.
2005: Ingunn Holen; Simon Cross; Helen L Neville-Webbe; Neil A Cross; Sabapathy P Balasubramanian; Peter I Croucher; Catherine A Evans; Jennifer M Lippitt; Robert E Coleman; Colby L Eaton
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?
Breast cancer research and treatment 2005;92(3):207-15.
2005: Helen L Neville-Webbe; Amin Rostami-Hodjegan; Catherine A Evans; Robert E Coleman; Ingunn Holen
Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells.
International journal of cancer. Journal international du cancer 2005;113(3):364-71.
2004: Helen L Neville-Webbe; Neil A Cross; Colby L Eaton; R Nyambo; Catherine A Evans; Robert E Coleman; Ingunn Holen
Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis.
Breast cancer research and treatment 2004;86(3):269-79.